(Total Views: 58)
Posted On: 02/26/2019 10:43:41 AM
Post# of 44493

$RGBP Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agonist To Treat for Inflammatory Bowel Disease @frontpagestocks https://seekingalpha.com/pr/17373562-regen-bi...flammatory

